Device / Technology News

RSS

NovoCure initiates newly-diagnosed GBM clinical trial

NovoCure, Ltd., a privately held medical device company focused on developing the Novo-TTF device, a non-invasive portable medical device for the treatment of cancer, announced the completion of a new funding round today. Key investors in this round included Pfizer Inc, Johnson & Johnson Development Corporation and Index Ventures.

29 Sep 2009

IPayX and ARM Solutions partner to offer collection services for hospitals and physicians’ offices

Internet Payment Exchange, a provider of electronic billing and payment (EBP) technology and customer service solutions to healthcare providers, utility companies, municipal governments and other organizations, announced an alliance with Ventura, Calif.-based Accelerated Revenue Management (ARM) Solutions to offer clients soft collection capabilities through IPayX’s eInvoice Delivery ServiceSM and eCareView Healthcare Billing PortalSM.

29 Sep 2009

Abnormal results on outpatient imaging tests may not receive timely follow-up, says report

Abnormal results on outpatient imaging tests sometimes may not receive timely follow-up even when clinicians receive and read results in an advanced, integrated electronic medical record system, according to a report in the September 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

29 Sep 2009

Conditional IDE approval for Flexstent Femoropopliteal Self Expanding Stent System

Flexible Stenting Solutions Inc. (“FSS”), a leading developer of next generation peripheral arterial and biliary stents, announced today that it has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent® Femoropopliteal Self Expanding Stent System.

29 Sep 2009

2009 International Society meeting to focus on hip arthroscopy

Recent advances in diagnostic imaging techniques and hip arthroscopy procedures are giving physicians and surgeons better tools with which to treat hip pain. The 2009 International Society for Hip Arthroscopy meeting, hosted by Hospital for Special Surgery in New York, brings together leading surgeons from all over the world to take an in-depth look at hip arthroscopy and its potential benefits.

29 Sep 2009

Mercy Memorial implements CDW's disaster recovery solution to increase reliability of critical clinical applications

CDW Healthcare, part of the public sector subsidiary of CDW Corporation and a leading provider of technology products and services to healthcare organizations, today announced that Mercy Memorial Hospital of Monroe, Mich., launched an extensive server virtualization and disaster recovery solution acquired from CDW Healthcare.

28 Sep 2009

Nuance launches eScription version 9 for for computer aided medical transcription

Nuance Communications, Inc., a leading supplier of speech solutions, today announced the availability of version 9 of its eScription on-demand platform for computer aided medical transcription (CAMT), a solution used by healthcare organizations to increase productivity and save costs associated with medical transcription (MT).

28 Sep 2009

The CDH Proton Therapy Center announces arrival of a 220-ton cyclotron for treating cancer

A 220-ton cyclotron, the core of what will soon be Illinois’ most advanced radiation treatment center, has ended a 5,000-mile journey that began in Belgium, arriving at the construction site of the CDH Proton Therapy Center, a ProCure Center, located in suburban Warrenville. Capable of accelerating protons, the cyclotron is the core piece of equipment used in proton therapy, an alternative to X-ray radiation that spares healthy tissue and results in far fewer short- and long-term treatment side effects.

28 Sep 2009

Preclinical data of CardiAQ Valve Technologies' TMVI in vivo study presented at the TCT 2009

Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for Transcatheter Mitral Valve Implantation (TMVI), announced today that successful results of an acute in vivo study of its TMVI system were disclosed by Dr. Joseph Bavaria during the “Mitral Valve Therapies Prior to and in Human Investigation” program at the “Transcatheter Cardiovascular Therapeutics (TCT) 2009” annual scientific meeting on Friday.

28 Sep 2009

The Children’s Hospital implements Eclipsys’ integrated decision support and analysis solution

Eclipsys Corporation®, The Outcomes Company®, today announced that pediatric hospitals are emerging as a key client base for its Sunrise EPSi™ integrated suite of business performance management solutions. In face of declining reimbursements, both acute and specialty care organizations are seeking the decision support solution as an effective means to become more efficient and improve productivity without sacrificing quality.

28 Sep 2009

World’s first Cesium-131 implant for recurrent head and neck cancer performed

IsoRay, Inc. (Amex: ISR) announced today that on August 5, 2009, Dr. Bhupesh Parashar from the Department of Radiation Oncology, Dr. David Kutler of the Department of Otorhinolaryngology, and Dr. Jason Spector of the Department of Plastic Surgery at Weill Cornell Medical Center performed the world’s first Cesium-131 implant for a recurrent head and neck cancer (buccal mucosa).

28 Sep 2009

PolyMedix receives patent protection for computational methods in the design of amphiphilic polymers

PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, “Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers.”

28 Sep 2009

Excelsior's SwabCap launched at the 23rd Association for Vascular Access conference

Excelsior Medical, one of the leading manufacturers of pre-filled catheter flush syringes and syringe pump systems, announced that it has launched a major new product: the SwabCap™ Luer Access Valve Disinfection Cap.

28 Sep 2009

Correlagen Diagnostics to develop diagnostic tests on the Helicos Genetic Analysis Platform

Helicos BioSciences Corporation (NASDAQ: HLCS) today announced the sale of a system and a scientific collaboration with Correlagen Diagnostics Inc., a leading provider of genetic tests for disease diagnosis.

28 Sep 2009

Correlagen to use Helicos Genetic Analysis System for diagnosing genetic disorders

Correlagen Diagnostics Inc., a leading provider of genetic testing for disease diagnosis, today announced the acquisition of a system from and a scientific collaboration with Helicos BioSciences Corporation.

28 Sep 2009

Austrian Institute of Technology adopts Arrayit's Microarray Platform for detecting dangerous pathogens

Arrayit Corporation, a proprietary life sciences and technology leader, disclosed that its Microarray Platform has been adopted by Austrian Institute of Technology.

28 Sep 2009

New Fragment Screening Platform from Selcia

Selcia Ltd, a worldwide industry leading C-14 custom radiolabelling provider and drug discovery company this week launched their new Fragment Screening Platform and unveiled their new brand as part of ambitious international expansion plans.

28 Sep 2009

New scalable solutions for targeted re-sequencing studies from febit holding and Life Technologies

febit holding GmbH and Life Technologies Corporation today announced that they have entered into a strategic co-marketing agreement to provide a new, scalable solution for researchers conducting targeted re-sequencing studies. In addition, febit will expand its Genomic Services Facility at Heidelberg by adding several Applied Biosystems SOLiD™ high-throughput sequencing systems and real-time PCR systems.

28 Sep 2009

MedShape Solutions to launch the FDA-cleared Morphix Suture Anchor device

MedShape Solutions, Inc. announced today the first FDA cleared shape memory PEEK (polyaryletheretherketone) device for orthopedics using proprietary shape memory PEEK Altera(TM) material. The Morphix(TM) Suture Anchor was recently granted FDA clearance and will be released to select U.S. markets in the coming months. Over $2.5B of PEEK-based implants are sold every year in the field of orthopedics.

28 Sep 2009

BIOLASE to market its Waterlase MD products in China

BIOLASE Technology, Inc. today announced that it finalized three regional distribution agreements in the People's Republic of China. This announcement follows the Company's August 12, 2009, announcement that it had received regulatory approval to market its Waterlase MD™ products in China.

28 Sep 2009

Device / Technology News

NovoCure initiates newly-diagnosed GBM clinical trial

IPayX and ARM Solutions partner to offer collection services for hospitals and physicians’ offices

Abnormal results on outpatient imaging tests may not receive timely follow-up, says report

Conditional IDE approval for Flexstent Femoropopliteal Self Expanding Stent System

2009 International Society meeting to focus on hip arthroscopy

Mercy Memorial implements CDW's disaster recovery solution to increase reliability of critical clinical applications

Nuance launches eScription version 9 for for computer aided medical transcription

The CDH Proton Therapy Center announces arrival of a 220-ton cyclotron for treating cancer

Preclinical data of CardiAQ Valve Technologies' TMVI in vivo study presented at the TCT 2009

The Children’s Hospital implements Eclipsys’ integrated decision support and analysis solution

World’s first Cesium-131 implant for recurrent head and neck cancer performed

PolyMedix receives patent protection for computational methods in the design of amphiphilic polymers

Excelsior's SwabCap launched at the 23rd Association for Vascular Access conference

Correlagen Diagnostics to develop diagnostic tests on the Helicos Genetic Analysis Platform

Correlagen to use Helicos Genetic Analysis System for diagnosing genetic disorders

Austrian Institute of Technology adopts Arrayit's Microarray Platform for detecting dangerous pathogens

New Fragment Screening Platform from Selcia

New scalable solutions for targeted re-sequencing studies from febit holding and Life Technologies

MedShape Solutions to launch the FDA-cleared Morphix Suture Anchor device

BIOLASE to market its Waterlase MD products in China

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News